Publications
5898 Results
- Journal / Conference
- 2025 ASCO Quality Care Symposium Oct 7, 2025; JCO Oncol Pract 21, 94(2025)
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
The special role of federal sponsorship in the design and conduct of drug or biological agent cancer treatment clinical trials.
- Journal / Conference
- 2025 ASCO Quality Care Symposium Oct 7, 2025; Abstract #36
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- Study Number(s)
- S1415CD
Impact of primary prophylactic colony stimulating factor delivery method on febrile neutropenia.
- Journal / Conference
- 2025 ASCO Quality Care Symposium Oct 7, 2025; Abstract #454
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
Composition of health care contact days and mortality prediction among trial participants.
- Journal / Conference
- 2025 ASCO Quality Care Symposium Oct 7, 2025; JCO Oncol Pract 21, 297(2025)
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- Study Number(s)
- S1417CD
Finance and work changes among caregivers of patients with metastatic colorectal cancer (mCRC): Secondary analysis of SWOG S1417CD.
- Journal / Conference
- ESMO Congress Sept 2025 Abstract 3140P
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- Study Number(s)
- S2108CD
Genomic tumor board (GTB) implementation in a cluster randomized controlled trial (RCT) comparing an educationally enhanced genomic tumor board (EGTB) intervention to usual practice (S2108CD, NCT# 05455606)
- Journal / Conference
- ICML 2025 Meeting (Lugano, Switzerland, June 17-21, 2025), e121_70093
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery and Lymphoma
- Study Number(s)
- CTSU/E1412
Influence Of Health Disparities (Hd) On Clinical Outcomes In Patients (Pts) With Diffuse Large B Cell Lymphoma (DLBCL) In The United States.
- Journal / Conference
- European Urology Feb;85(2):171-176
- Year
- 2024
- Research Committee(s)
- Genitourinary
- PMID
- PMID37085425
- PMC
- PMC10662935
- Study Number(s)
- S1216
Bone biomarkers and subsequent survival in men with hormone sensitive prostate cancer: results from the SWOG S1216 phase III trial of androgen deprivation therapy with or without orteronel
- Journal / Conference
- Leukemia Jan;38(1):58-66
- Year
- 2024
- Research Committee(s)
- Leukemia
- PMID
- PMID37935977
- Study Number(s)
- S1203
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML
- Journal / Conference
- Clinical Cancer Research Jan 17;30(2):444-449
- Year
- 2024
- Research Committee(s)
- Genitourinary
- PMID
- PMID37966367
- PMC
- PMC10824507
- Study Number(s)
- S1314
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
- Journal / Conference
- Clinical Cancer Research Jan 5;30(1):33-38
- Year
- 2024
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID37882676
- PMC
- PMC10842092
- Study Number(s)
- S1609